Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT Study - Mahe, I; Agnelli, G; Bamias, A; Ay, C; Becattini, C; Carrier, M (Thromb Haemost, 2022)